Pancreatic Cell News Volume 13.29 | Jul 26 2022

    0
    29








    2022-07-26 | PACN 13.28


    Pancreatic Cell News by STEMCELL Technologies
    Vol. 13.28 – 26 July, 2022
    TOP STORY

    Inhibition of Pancreatic EZH2 Restores Progenitor Insulin in T1D Donor

    Scientists demonstrated that GSK126, a highly selective inhibitor of EZH2 methyltransferase activity influenced H3K27me3 chromatin content and transcriptional control resulting in the expression of core β-cell markers and ductal progenitor genes.
    [Signal Transduction and Targeted Therapy]

    Full ArticlePress Release
    Subscribe to Science News for free weekly science newsletters.
    PUBLICATIONSRanked by the impact factor of the journal

    14-3-3-Zeta Mediates GLP-1 Receptor Agonist Action To Alter α Cell Proglucagon Processing

    Researchers characterized the bidirectional paracrine cross-talk by which α and β cells communicated to mediate the effects of the glucagon-like peptide-1 receptor (GLP-1R) agonist, liraglutide.
    [Science Advances]

    Full Article

    A Critical Role of the Mechanosensor PIEZO1 in Glucose-Induced Insulin Secretion in Pancreatic β-Cells

    Investigators reported that β-cell-specific Piezo1 -knockout mice showed impaired glucose tolerance in vivo and reduced glucose-induced insulin secretion, β-cell electrical activity and Ca2+ elevation in vitro.
    [Nature Communications]

    Full Article

    Identification and Implication of Tissue-Enriched Ligands in Epithelial–Endothelial Crosstalk During Pancreas Development

    Functional experiments on ex vivo cultured pancreatic explants indicated that tip cell-produced bone morphogenetic protein 7 limited development of endothelial cells.
    [Scientific Reports]

    Full Article

    G6PD-Mediated Increase in De Novo NADP+ Biosynthesis Promotes Antioxidant Defense and Tumor Metastasis

    Scientists reported that knocking down glucose-6-phosphate dehydrogenase (G6PD) impeded pancreatic cancer metastasis, whereas forced G6PD expression promoted it.
    [Science Advances]

    Full Article

    O-GlcNAcylation Promotes Pancreatic Tumor Growth by Regulating Malate Dehydrogenase 1

    Researchers demonstrated that depletion of O-GlcNAcylation reduced malate dehydrogenase 1 activity, impaired glutamine metabolism, sensitized PDAC cells to oxidative stress, decreased cell proliferation and inhibits tumor growth in nude mice.
    [Nature Chemical Biology]

    Full ArticleGraphical Abstract

    Thiostrepton Induces Ferroptosis in Pancreatic Cancer Cells Through STAT3/GPX4 Signaling

    Investigators reported that thiostrepton reduced the viability and clonogenesis of pancreatic cancer cell lines, along with intracellular iron overload, increasing reactive oxygen species accumulation, malondialdehyde overexpression, and glutathione peroxidase depletion.
    [Cell Death & Disease]

    Full Article

    PCDH1 Promotes Progression of Pancreatic Ductal Adenocarcinoma via Activation of NF-κB Signaling by Interacting with KPNB1

    The authors reported that Protocadherin 1 (PCDH1) expression was upregulated in PDAC tissues, and its expression levels were associated with the depth of tumour invasion and lymph node metastasis.
    [Cell Death & Disease]

    Full Article

    FZD7 Accelerates Hepatic Metastases in Pancreatic Cancer by Strengthening EMT and Stemness Associated with TGF-β/SMAD3 Signaling

    The expression of Frizzled receptor 7 in pancreatic ductal adenocarcinoma and relating survival rate were analyzed by bioinformatics, histochemistry assay and follow-up study.
    [Molecular Medicine]

    Full Article
    Easy250 EasySep Magnet for rapid immune cell isolation from large-volume samples.
    REVIEWS

    Emerging Molecular Technologies for Light-Mediated Modulation of Pancreatic Beta-Cell Function

    The molecular circuit of the glucose-stimulated insulin secretion in β-cells is described with emphasis on intermediates which are targetable for optical intervention.
    [Molecular Metabolism]

    Full Article

    INDUSTRY AND POLICY NEWS

    Propanc Biopharma Successfully Produces Synthetic Recombinant Trypsinogen via POP1 Joint Research & Drug Discovery Program

    Propanc Biopharma, Inc. announced that successful production of a synthetic recombinant version of the proenzyme trypsinogen was completed via the Proenzyme Optimization Project 1 oint research and drug discovery program.
    [Propanc Biopharma, Inc.]

    Press Release
    FEATURED EVENT

    The Gastrointestinal Tract XX Conference: Making and Breaking the Gut

    Aug 7 – 12, 2022
    Steamboat Springs, Colorado, United States

    > See All Events

    JOB OPPORTUNITIES

    Faculty Position – Cancer Biology

    Mayo Clinic – Scottsdale, Arizona, United States

    Postdoctoral Scholar – Beta Cell Biology

    Carver College of Medicine – Iowa City, Iowa, United States

    Associate Professor – Thematic Research Programs

    The Chinese University of Hong Kong – Hong Kong, China

    Postdoctoral Position – Cancer Research

    Albert Einstein College of Medicine – Bronx, New York, United States

    Research Assistant Professor – Cardiovascular and Regenerative Medicine

    Ohio State University Wexner Medical Center – Columbus, Ohio, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Pancreatic Cell News Twitter